Our innovative processes include protocol design, site training, and real time data quality analysis

乐和彩开户cns drug development norms are being challenged. nowadays clinical development programs in the central nervous system (cns) reach the highest failure rates across all therapeutic areas. unsurprisingly this had led to a challenging of accepted and established norms by cns drug developers.

you can minimise risk and maximise your probability of success through:

  • Access to the latest, applied technology innovation and processes
  • Working with our highly qualified and therapeutically trained staff
  • Real time data quality monitoring and analysis

ICON CNS experience in last five years

  • 157

    Studies conducted
  • 42,000

    Patients involved
  • 5,700

    Sites worldwide

Services for CNS, Pain and Ageing Diseases

Our Protocol and Clinical Development Plans service is complemented with Adaptive Design competency and regulatory approved software乐和彩开户. Our full service study/program implementation and execution includes: 

Dedicated specialist teams

All staff assigned to projects including; Project Management, Drug Development, Site Identification and Feasibility, and Medical oversight attend customised training programs. Over the past 5 years ICON have conducted phase II & III studies in a range of CNS indications. We also offer dedicated teams for rare and paediatric CNS programs.